The epidemiology of systemic lupus erythematosus
References (100)
- et al.
The immunology and pathology of NZB mice
- et al.
A transplacental factor in the disease of the autoimmune NZB/BL mouse
Lancet
(1969) The serum protein pattern of West Africans in Britian
Tr Roy Soc Trop Med Hyg
(1957)A population study on serum immunoglobulin levels
Clin Chim Acta
(1970)Systemic lupus erythematosus—Disease of unusual immunologic responsiveness?
Am J Med
(1959)- et al.
The epidemiology of polymyositis
Amer J Med
(1970) - et al.
Systemic lupus erythematosus in pregnancy
Am J Obstet Gynecol
(1970) - et al.
Hereditary hypergammaglobulinemia and systemic lupus erythematosus. 1. Clinical and electrophoretic studies
Acta Med Scand
(1959) Tissue typing and organ transplantation
Lancet
(1969)- et al.
Seven new HL-A specificities and their distribution in 3 races
Cytoplasmic tubular structures in kidney biopsies in patients with systemic lupus erythematosus (SLE) and in patients with various renal diseases
Arthritis Rheum
Demonstrations of microtubular inclusions in cell cultures of systemic lupus erythematosus (SLE) skin
Arthritis Rheum
Microtubules of systemic upus erythematosus
Lancet
Viral isolation studies of inclusion positive biopsy from human connective tissue diseases
Arthritis Rheum
Myxovirus antibody increases in human connective tissue disease
Science
Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases
Arch Intern Med
Correspondence
Lancet
Measles antibodies in sera from patients with autoimmune diseases
Lancet
Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases
Arthritis Rheum
Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases
Medicine
The epidemiology of systemic lupus erythematosus. Results of a population study in New York City
Preliminary criteria for the classification of systemic lupus erythematosus
Bull Rheum Dis
Epidemiologie studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956–1965
Arth Rheum
Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951–1967, with special reference to systemic lupus erythematosus
Incidence of disseminated lupus erythematosus. Follow-up studies indicating increased frequency
JAMA
Family studies in systemic lupus erythematosus
Acta Med Scand
Lupus Erythematosus. A Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Variants
Systemic Lupus Erythematosus
Disseminated (systemic) lupus erythematosus
Racial and social factors in systemic lupus erythematosus
JAMA
Incidence of systemic lupus erythematosus by age and sex
JAMA
Immunopathology of NZB/BL mice, V. Viruslike (filterable) agent separable from lymphoma cells and identifiable by electron microscopy
J Exp Med
Racial differences in serum gamma globulin levels: Comparative data for Negroes, Puerto Ricans and other Caucasians
J Lab Clin Med
Racial differences in Mantoux reaction after BCG vaccination: Implications in systemic lupus erythematosus
Am Rev Resp Dis
Gammaglobulins and their clinical significance. 1. Chemistry, immunology and metabolism
N Engl J Med
Serum protein concentration in the North American Negroid
Science
Observations on electrophoresis of serum proteins from healthy North American Caucasian and Negro subjects and from patients with systemic lupus erythematosus
J Lab Clin Med
Differences between the normal serum protein patterns of American Indian, Negro and Caucasian subjects
The distribution of the serum immunoglobulins, antigamma G globulins (“rheumatoid factors”) and antinuclear antibodies in white and Negro subjects in Evans County, Georgia
Arth Rheum
Effect of race and stage of disease on the serum immunoglobulins in sarcoidosis
JAMA
Immunoglobulins G, A and M in systemic lupus erythematosus. Relationship to serum complement titer, latex titer, antinuclear antibody and manifestations of clinical disease
Ann Intern Med
The influence of heredity and environment on human immunoglobulin levels
J Immunol
Epidemiologic study of Hashimoto's disease
Arthritis Rheum
Studies of delayed hypersensitivity in systemic lupus erythematosus
Ann Rheum Dis
In vivo and in vitro study of cell-mediated immunity during the onset of systemic lupus erythematosus
Arthritis Rheum
Cellular immunity to nuclear antigens in systemic lupus erythematosus
Arthritis Rheum
Viruses and the connective tissue diseases
Ann Intern Med
Epidemiology of fatal systemic sclerosis (diffuse scleroderma)
Ann Intern Med
Rheumatoid arthritis in a subtropical population
Ann Rheum Dis
The rarity of ankylosing spondylitis in the black race
Arthritis Rheum
Cited by (210)
Drug allergy and autoimmune diseases
2022, Allergology InternationalCitation Excerpt :It is characterized by abnormalities in autoimmune antibodies and a wide variety of clinical manifestations. SLE prevalence in European populations ranges from 17 to 48 cases per 100,000 people.21,22 The incidence in men and women has been estimated at 3–7 and 45–4 cases per 100,000 people per year, respectively.23
16 α-Hydroxyestrone induced adduct generate high affinity autoantibodies in SLE
2019, Advances in Medical SciencesEffective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring
2017, American Journal of the Medical SciencesPatient-Reported Outcomes in Systemic Lupus Erythematosus
2016, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Treatment of more severe cases of SLE often involves a balance between managing the manifestations of the disease and minimizing the treatment-related side effects. The disease has a significant impact on many aspects of patients’ lives and their overall well-being, or health-related quality of life (HRQOL) because SLE affects a relatively younger age group and improved survival has translated into longer disease duration.1–3 Therefore, patients with SLE must cope with a significant disease burden imposed by the numerous symptoms of the disease itself and its treatment, including fatigue, pain, sleep disturbance, renal and skin problems, and neurologic/psychiatric conditions (eg, anxiety, depression, headaches, motor/sensory deficits, seizures, cognitive impairment, neuropathy).4–10
- 1
From the Department of Environmental Medicine and Community Health, State University of New York, College of Medicine at New York City.
- 2
From the Department of Medicine, Jewish Hospital and Medical Center of Brooklyn, New York.